Integrated Measurement for Early Detection (MIDO) as a digital strategy for timely assessment of non-communicable disease profiles and factors associated with unawareness and control: a retrospective observational study in primary healthcare facilities in Mexico.
Héctor Gallardo-RincónAlejandra MontoyaRodrigo Saucedo-MartínezRicardo Mújica-RosalesLorena Suárez-IduetaLuis Alberto Martínez-JuárezChristian RazoRafael LozanoRoberto Tapia-ConyerPublished in: BMJ open (2021)
Patient-centred screening strategies such as MIDO are urgently needed to improve screening, access, retention and control for patients with NCDs.
Keyphrases